Prescribing patterns of antipsychotics in 13 French psychiatric hospitals;Enquête de pratiques de prescription des antipsychotiques dans 13 centres hospitaliers du réseau PIC

Encephale

Volumn 35, Issue 2, 2009, Pages 129-138

  Bret, P ^a   Bret, M C ^a   Queuille, E ^a  

^a CENTRE HOSPITALIER CHARLES PERRENS   (France)

Author keywords

Antipsychotics; Guidelines; Neuroleptics; Prescribing practices

Indexed keywords

ALIMEMAZINE; AMISULPRIDE; ANTIPARKINSON AGENT; CARBAMAZEPINE; CHLORPROMAZINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLONAZEPAM; CLOZAPINE; CYAMEMAZINE; FLUPENTIXOL; HALOPERIDOL; HYDROXYZINE; LEVOMEPROMAZINE; LITHIUM; LOXAPINE; NEUROLEPTIC AGENT; OLANZAPINE; PAROXETINE; PERICIAZINE; PIMOZIDE; RISPERIDONE; SULPIRIDE; SULTOPRIDE; THIORIDAZINE; TIAPRIDE; UNINDEXED DRUG; VALPROATE SEMISODIUM; VENLAFAXINE; ZOPICLONE; ZUCLOPENTHIXOL;

ADULT; AROUSAL; ARTICLE; BIPOLAR DISORDER; CLINICAL PRACTICE; CLINICAL PROTOCOL; CLINICAL TRIAL; COGNITION; COMORBIDITY; COMPARATIVE STUDY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DRUG TOLERABILITY; FRANCE; HEALTH SURVEY; HOSPITAL PATIENT; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MEDICAL EDUCATION; MENTAL DISEASE; MENTAL HOSPITAL; MONOTHERAPY; MULTICENTER STUDY; NATURALISTIC INQUIRY; NEUROLOGY; OBSERVATIONAL METHOD; PATIENT COMPLIANCE; PRACTICE GUIDELINE; PRESCRIPTION; PSYCHIATRIST; PSYCHIATRY; PSYCHOPHARMACOLOGY; QUALITY OF LIFE; RISK REDUCTION; SCHIZOPHRENIA; UNSPECIFIED SIDE EFFECT;

ADULT; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; CROSS-SECTIONAL STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; DRUG PRESCRIPTIONS; DRUG THERAPY, COMBINATION; DRUG UTILIZATION; FEMALE; FRANCE; HOSPITALS, PSYCHIATRIC; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; PSYCHOTIC DISORDERS;

EID: 67349157526     PISSN: 00137006     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.encep.2008.03.007     Document Type: Article

References (16)

1. American Psychiatric Association (APA). Practice guideline for the treatment of bipolar patients. 2nd ed; 2002 [ www.psych.org/psych-pract/treatg/ pg/prac-guide.cfm ].
2. C. Barbui , A. Ciuna , and M. Nose Off-label and non-classical prescriptions of antipsychotic agents in ordinary in-patient practice Acta Psychiatr Scand 109 2004 275 278 (Pubitemid 38406709)
3. M.C. Bret , P. Bret , and A. Pariente How are atypical antipsychotics used in French psychiatric hospitals? Pharm World Sci 29 5 2007 551 556
4. P. Bret , F. Bonnet , and M.C. Bret Étude des pratiques de prescription des neuroleptiques dits atypiques ou antipsychotiques atypiques au Centre Hospitalier Ch. Perrens Encéphale 28 2002 329 342
5. A. Brunot , B. Lachaux , and H. Sontag Étude pharmacoé pidémiologique de la prescription des antipsychotiques en milieu psychiatrique en France Encéphale 28 2002 129 138
6. Fédération Française de Psychiatrie. Stratégies thérapeutiques à long terme dans les psychoses schizophréniques. Paris: Frison-Roche; 1994. [Conférence De Consensus].
7. Fédération Française de Psychiatrie. Schizophrénies débutantes : diagnostics et modalités thérapeutiques. Paris; 2003. [Conférence De Consensus. http://psydoc-fr.broca.inserm.fr ].
8. A. Fourrier , I. Gasquet , and M.P. Allicar Patterns of neuroleptic drug prescription: a national cross-sectional survey of a random sample of French psychiatrists Br J Clin Pharmacol 49 2000 80 86 (Pubitemid 30050490)
9. C. Gury , F. Berchot , and C. Fabre Analyse des prescriptions de neuroleptiques dans cinq centres hospitaliers spécialisés Inf Psychiatr 76 8 2000 954 963
10. C. Gury , C. Fabre , and A. Hameg Prescriptions dantipsychotiques en milieu hospitalier spécialisé Inf Psychiatr 82 6 2006 503 509 (Pubitemid 44257302)
11. C. Haw , and J. Stubbs A survey of off-label prescribing for inpatients with mild intellectual disability and mental illness J Intellect Disabil Res 14 11 2005 805 811 (Pubitemid 41600769)
12. A.F. Lehman , J.A. Lieberman , and L.B. Dixon American Psychiatric Association. Practice guideline for the treatment of patients with schizophrenia, 2nd ed Am J Psychiatry 161 2004 1 56 (Pubitemid 38425473)
13. National Institute for Clinical Excellence (NICE). Schizophrenia: core interventions in the treatment and management of schizophrenia in primary and secondary care; 2002: 1-64, and Guidance on the use of newer atypical antipsychotic drugs for the treatment of schizophrenia; 2002): 1-20. [on http://www.nice.org.uk/ ]
14. National Institute for Clinical Excellence (NICE). Bipolar disorder: the management of Bipolar disorder in adults, children, and adolescents, in primary and secondary care; 2006 [on http://www.nice.org.uk/gc38 ].
15. S. Orhon-Menard , A. Garcel , and I. De Beauchamp Évolution des pratiques de prescription des psychotropes en Centre Hospitalier psychiatrique, place des NL atypiques J Pharm Clin 24 1 2005 5 10 (Pubitemid 40470557)
16. Working Group for the Canadian Psychiatric Association. Clinical practice guidelines: treatment of schizophrenia. Can J Psychiatry 2005;50 (suppl. 1).